BPC-157 vs KPV

Two different routes to the same gut problem

Both are reached for in inflammatory bowel conditions, and both are animal-data-only. They get there differently. BPC-157 comes from stomach juice and is associated with protecting and repairing the gut lining. KPV is the tail end of alpha-MSH and is actively carried into inflamed colon tissue by PepT1, a transporter that is overexpressed exactly where the inflammation is, an unusually targeted delivery mechanism. KPV is also taken orally for this purpose, where BPC-157 is usually injected unless the complaint is gut-specific.

Human skeletal muscle fibres joining a collagen tendon.

BPC-157 Healing & repair Body Protection Compound 157 Full entry →

Intestinal epithelial lining with closely packed cells and subtle microvilli, mucosal research imagery.

KPV Immune α-MSH (11-13) Full entry →

BPC-157 compared with KPV
	BPC-157	KPV
Evidence behind it	Animal studies	Animal studies
Worth knowing	Essentially all of this is rodent data. There are no published controlled human trials, and claims about joint or gut healing in people are extrapolation.	Animal and cell data only.
Approval	Research only	Research only
Category	Healing & repair	Immune
What it is	A 15-amino-acid synthetic peptide based on a protein fragment found in stomach juice. In animal studies it has been linked to faster healing of tendon, muscle, gut and skin injuries, new blood vessel growth, and effects on nitric oxide signaling.	The last three amino acids of alpha-melanocyte-stimulating hormone. It keeps much of that hormone's anti-inflammatory activity without causing skin darkening. It is studied mainly for gut inflammation such as colitis, and for skin inflammation.
How it works	Derived from a protein in gastric juice. Reported to upregulate growth hormone receptors via the phospholipase C pathway and to drive angiogenesis — new blood vessel growth into damaged tissue.	The last three amino acids of alpha-MSH. It is carried into gut and immune cells by PepT1, a peptide transporter that is overexpressed in inflamed colon tissue, where it dampens NF-κB signalling. Being this short, it keeps the anti-inflammatory action without the melanocortin receptor binding that causes skin darkening.
What studies report	Faster tendon, ligament and muscle healing in rat injury models Protection of the stomach and gut lining against NSAID and alcohol damage in rodents New blood vessel growth at injury sites in animals	Reduced colitis severity in mouse models, including when given orally Anti-inflammatory effects in skin, gut and joint models Keeps the anti-inflammatory action of alpha-MSH without skin darkening
Dosing	Reported, not evidence 250–500 mcg daily, subcutaneous, is the most commonly cited range Often injected near the injury site for tendon and ligament work Run in 4–8 week blocks Oral capsules used instead for gut complaints	Reported, not evidence 200–500 mcg daily, oral capsules for gut use Topical for skin conditions
Why people take it	Achilles and other tendon tearsACL and meniscus injuryRotator cuff tearsIT band syndromeGut lining, GERD and ulcersTendon, ligament and muscle injury	Gut inflammation and IBDSkin inflammationGeneral anti-inflammatory use
In practice	Among the most widely used peptides in the injury-recovery community, usually run in 4–8 week blocks Commonly injected near the injury site for tendon and ligament problems, or systemically Oral and capsule forms are preferred for gut complaints, since it originates in the digestive tract Routinely stacked with TB-500 — the pairing is common enough to have its own nickname Sold pre-blended with thymosin-β4 as a “Wolverine stack”, and in four-way GHK and KPV blends, so buyers often take several peptides without measuring any of them separately	Taken orally in capsules for gut inflammation Applied topically for inflammatory skin conditions Popular in the inflammatory bowel community Appears in four-way pre-mixed blends with BPC-157, thymosin-β4 and GHK
Route	Subcutaneous injection; oral and capsule forms are used for gut complaints; also sold as a ready-made intranasal spray	Oral capsule or topical; occasionally injected

Rows describing reported use say what people do, not what has been shown to work. Evidence strength is graded the same way across the whole library, so the two columns are directly comparable.

Read the full entries

BPC-157 → KPV → Open this in the compare tool →

Other comparisons

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Comparing two compounds is not a suggestion to take either one. Talk to a licensed clinician before acting on anything you read here. How to read these entries.